BaseSpace
Correlation
Engine-Public
Sign In
Register
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Metabolism of nitric oxide
,
Tamoxifen
,
rs7903146
,
MYC
,
Coagulation
,
Obesity
,
Heart
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
CEBPA
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Liver
Adipose tissue subcutaneous
Adipose tissue
Omental adipose tissue
Nipple cross-section
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Loading...
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Loading...
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Loading...
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
An intronic enhancer of Cebpa regulates adipocyte differentiation and adipose tissue development via…
Targeting CEBPA to restore cellular identity and tissue homeostasis in pulmonary fibrosis.
1-Deoxynojirimycin affects high glucose-induced pancreatic beta-cell dysfunction through regulating …
CEBPA restricts alveolar type 2 cell plasticity during development and injury-repair.
TRβ activation confers AT2-to-AT1 cell differentiation and anti-fibrosis during lung repair via KLF2…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Study of MTL-CEBPA in Combination With a PD-1 Inhibitor in Patients With Advanced Solid Tumours (T…
Intermediate-dose HAD Regimen for CEBPA Double-mutated AML
Radomised Phase II Study of MTL-CEBPA Plus Sorafenib or Sorafenib Alone
Efficacy of HAD Induction With Intensified Cytarabine in Newly-diagnosed CEBPA Double Mutated Acute …
First-in-Human Safety, Tolerability and Antitumour Activity Study of MTL-CEBPA in Patients With Adva…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ